🇺🇸 FDA
Patent

US 9914775

Methods for treating inflammatory disorders or cancer metastasis by administering antibodies to connexin 43 (Cx43) hemichannels

granted A61KA61K49/0008A61P

Quick answer

US patent 9914775 (Methods for treating inflammatory disorders or cancer metastasis by administering antibodies to connexin 43 (Cx43) hemichannels) held by The Board of Regents of the University of Texas System expires Mon Mar 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Mar 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61K, A61K49/0008, A61P, A61P19/02